Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for the initial treatment of venous thromboembolism
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Fixed Dose Subcutaneous Low Molecular Weight Heparins Versus Adjusted Dose Unfractionated Heparin for the Initial Treatment of Venous Thromboembolism." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431752/2/images/. Accessed 17 May 2024.
Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for the initial treatment of venous thromboembolism. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431752/2/images/. Accessed May 17, 2024.
Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for the initial treatment of venous thromboembolism. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/431752/2/images/
Fixed Dose Subcutaneous Low Molecular Weight Heparins Versus Adjusted Dose Unfractionated Heparin for the Initial Treatment of Venous Thromboembolism [Internet]. In: Cochrane Abstracts. [cited 2024 May 17]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431752/2/images/.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for the initial treatment of venous thromboembolism
ID - 431752
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431752/2/images/
DB - Evidence Central
DP - Unbound Medicine
ER -